Herskowitz Neil
CIK 0001298246
Director
Filings
16
Latest Dec 30, 2025
Issuers covered
4
Showing
16 of 16
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -0.8% | -0.8% | +0.5% | -2.2% |
| 90 days | 2 | 100% | +35.8% | +35.8% | +48.0% | +23.7% |
| 180 days | 1 | 100% | +87.1% | +87.1% | +87.1% | +87.1% |
| 365 days | 1 | 100% | +53.9% | +53.9% | +53.9% | +53.9% |
Issuers
Companies where Herskowitz Neil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CKPT | Checkpoint Therapeutics, Inc. | 5 | May 30, 2025 |
| DERM | Journey Medical Corp | 5 | Aug 7, 2025 |
| ATXI | Avenue Therapeutics, Inc. | 3 | Dec 3, 2024 |
| MBIO | Mustang Bio, Inc. | 3 | Dec 30, 2025 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|